|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Micropuncture study of acute renal failure following temporary renal ischemia in the rat显示文摘 | Arendshorst WJ Finn WF Gottschalk CW | 1976 | Kidney/nt1976，106，： | 1 |
| 2 | Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate:a new phosphate binder for the treatment of hyperphosphatemia显示文摘 | Joy MS Finn WF | 2003 | Am J Kidney Dis2003，42，1： | 1 |
| 3 | Recovery from postischemic acute renal failure in the rat显示文摘 | Finn WF Chevalier RL | 1979 | Kidney Int1979，16，2： | 1 |
| 4 | The phosphate binder equivalent dose 显示文摘 | Daugirdas JT Finn WF Ernmett M | 2011 | Seminars Dial2011，24，： | 1 |
| 5 | Cognitive function in stage 5chronic kidney disease patients on hemodialysis: no adverseeffects of lanthanum carbonate compared with standard phosphate- binder therapy显示文摘 | Altmann P Barnett ME Finn WF | 2007 | Kidney Int2007，71，： | 1 |
| 6 | Efficacy and safety of lanthanum car-bonate for reduction of serum phosphorus in patientswith chronicrenal failure receiving hemodialysis显示文摘 | Finn WF Joy MS Hladik G | 2004 | ClinNephro2004，62，3： | 1 |
| 7 | Lanthanum carbonate versus standard therapy for the treat- ment of hyperphosphatemia: safety and efficacy in chronic maintenance hemodialysis patients 显示文摘 | Finn WF | 2006 | Clinical Nephrology2006，65，3： | 1 |
| 8 | Compensatory renal hypertrophy in Sprague - Dawley rats: Glomerular uhrafiltration dynamics 显示文摘 | Finn WF | 1982 | Ren Physiol1982，5，5： | 1 |
| 9 | The clinical and renal consequences of contrast-induced nephropathy显示文摘 | Finn WF | 2006 | Nephrol Dial Transplant2006，21，6： | 1 |
| 10 | FK506 nephrotoxicity 显示文摘 | Finn WF | 1999 | Ren Fail1999，21，34： | 1 |
| 11 | Efficacy and safety of lanthanum carbonate for reduction of serum phosphorus in patients with chronic re- nal failure receiving hemodialysis 显示文摘 | Finn WF Joy MS Hladik G | 2004 | Clin Nephrol2004，62，3： | 1 |
| 12 | New approaches for detecting threshold of human nephrotoxicity using cadmium as an example 显示文摘 | Mueller PW Price RG Finn WF | 1998 | Environ Health Perspect1998，106，： | 1 |
| 13 | Randomized, double-blind, placebo-controlled, dose-titration, phase nl study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia 显示文摘 | Joy MS Finn WF LAM -302 Study Group | 2003 | American Journal of Kidney Diseases2003，42，1： | 1 |
| 14 | New approcaches for detecting thresholds of human nephrotoxicity using cadmium as an example显示文摘 | Mueller PW Price RG Finn WF | 1998 | Environ Health Perspect1998，106，5： | 1 |
| 15 | A long-term,open-label extension study on the safety of treatment with lanthanum carbonate,a new phosphate binder,in patients receiving hemodialysis显示文摘 | Finn WF Joy MS | 2005 | Curr Med Res Opin2005，21，： | 1 |
| 16 | The clinical and renal consequences of contrast- induced nephropathy显示文摘 | Finn WF | 2006 | Nephrol Dial Transplant2006，21，6： | 1 |
| 17 | Cognitive function in stage 5 chronic kidney disease patients on hemddialysis: no adverse effects of lanthanum carbonate compared with standard phosphate-binder therapy显示文摘 | Altmann P Barnett ME Finn WF | 2007 | Kidney Int2007，71，： | 1 |
| 18 | The effects of aldose reductase inhibitors in diabetic nephropathy显示文摘 | Mc Cormack AJ Finn WF | 1989 | Diabets Comqlications1989，3，1： | 1 |
| 19 | Randomized,double-blind,placebo-controlled,dose-titration,phaseⅢstudy assessing the efficacy and tolerability of lanthanum carbonate:a new phosphate binder for the treatment of hyperphosphatemia显示文摘 | Joy MS Finn WF | 2003 | Am J Kidney Dis2003，42，1： | 1 |
| 20 | Efficacy and safety of lanthanum carbonate for reduction of serum phosphorus in patients with chronic renal failure receiving hemodialysis显示文摘 | Finn WF Joy MS Hladik G | 2004 | Clin Nephrol2004，62，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员